Trade groups urge pause on sweeping Medicare Advantage rules
(By Rylee Wilson for Becker’s Hospital Review) An organization representing Medicare Advantage insurers is asking CMS to pause any policy
Read More
Health Care Finance
Claims Denials and Appeals in ACA Marketplace Plans in 2023
(By Justin Lo, Michelle Long, Rayna Wallace, Meghan Salaga, and Kaye Pestaina for The Kaiser Family Foundation Published: Jan 27,
Read MoreThis 2025 Medicare Change could reduce out-of-pocket expenses
Medicare changes every year, and 2025 was no exception. Although those changes usually involve higher premiums and deductibles for recipients,
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 23, 2025) The Inflation Reduction Act of 2022 (the Act),
Read More2026 Medicare Advantage rates ‘inadequate,’ Elevance execs say
(By Rylee Wilson for Becker’s Hospital Review) CMS’ proposed Medicare Advantage rates for 2026 are moving in the right direction,
Read MoreMedicare Advantage enrollment has increased
Of the Medicare-eligible individuals, 54 percent are enrolled in Medicare Advantage plans. Why has Medicare Advantage plan enrollment increased as
Read MoreCMS issues flurry of Medicare fines to payers
(By Jakob Emerson for Becker’s Hospital Review) CMS issued nearly $2.5 million in fines on Jan. 17 across multiple health
Read MoreHow Many Physicians Have Opted Out of the Medicare Program?
(By Alex Cottrill, Nancy Ochieng, and Tricia Neuman for The Kaiser Family Foundation Published: Jan 17, 2025) Medicare provides health
Read MoreUnitedHealth’s plan to defend its PBM: 5 things to know
(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will pass 100% of the rebates it negotiates for drugs onto its
Read MoreMedicare targets 15 more drugs for price negotiations
(By Sydney Lupkin for NPR) The Biden administration, in its last full weekday in office, is poised to announce the
Read More